Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program

Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program

Raffaele Campisi,1 Claudia Crimi,1 Santi Nolasco,2 Bianca Beghè,3 Leonardo Antonicelli,4 Gabriella Guarnieri,5 Nicola Scichilone,6 Morena Porto,2 Luigi Macchia,7 Giulia Scioscia,8 Maria Pia Foschino Barbaro,8 Alberto Papi,9 Nunzio Crimi1,2 1Respiratory Medicine Unit, A.O.U. Policlinico &a...

Full description

Bibliographic Details
Main Authors: Campisi R, Crimi C, Nolasco S, Beghè B, Antonicelli L, Guarnieri G, Scichilone N, Porto M, Macchia L, Scioscia G, Foschino Barbaro MP, Papi A, Crimi N
Format: Article
Language:English
Published: Dove Medical Press 2021-05-01
Series:Journal of Asthma and Allergy
Subjects:
severe asthma
named patient program
oral corticosteroids
real-world
dupilumab
Online Access:https://www.dovepress.com/real-world-experience-with-dupilumab-in-severe-asthma-one-year-data-fr-peer-reviewed-fulltext-article-JAA

Internet

https://www.dovepress.com/real-world-experience-with-dupilumab-in-severe-asthma-one-year-data-fr-peer-reviewed-fulltext-article-JAA

Similar Items